Answer
The selected Relevtec and Bupeaze patches are not licensed for acute pain because absorption through the skin is gradual.
Sources for this answer
- Relevtec 35 microgram/hour transdermal patch — Current selected SmPCemc · Summary of Product Characteristics
- Bupeaze 70 micrograms/h Transdermal Patches — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.